Finance

Lists
Q1 2027 earnings
See results
WOCKPHARMA:NSE
Wockhardt Ltd
₹1,932.50
+1.02%
(+19.60) 1D
Aug 14, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for WOCKPHARMA...
Open
₹1,916.00
High
₹1,959.30
Low
₹1,908.10
Mkt. cap
315.15B
Avg. vol.
0.00
Volume
480.22K
P/E ratio
76.77
52-wk high
₹2,422.30
52-wk low
₹1,086.70
EPS
₹25.17
Shares outstanding
110.69M
No. of employees
3K
Open
₹1,916.00
High
₹1,959.30
Low
₹1,908.10
Mkt. cap
315.15B
Avg. vol.
0.00
Volume
480.22K
P/E ratio
76.77
52-wk high
₹2,422.30
52-wk low
₹1,086.70
EPS
₹25.17
Shares outstanding
110.69M
No. of employees
3K
Profile
Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company has manufacturing plants in India, the UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. Wikipedia
About Wockhardt Ltd
CEOMurtaza Khorakiwala
Employees2.56K
Founded1967
Headquarters-
SectorPharmaceutical industry
Websitewockhardt.com
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
9.60B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.82B
8.88B
10.54B
9.60B
Cost of goods sold
2.33B
3.17B
4.03B
3.20B
Cost of revenue
2.33B
3.17B
4.03B
3.20B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.86B
1.81B
1.90B
2.03B
Operating expense
4.42B
4.63B
4.19B
4.76B
Total operating expenses
6.75B
7.80B
8.22B
7.96B
Operating income
1.07B
1.08B
2.32B
1.64B
Other non operating income
210.00M
250.00M
-710.00M
-
EBT including unusual items
910.00M
670.00M
1.89B
1.16B
EBT excluding unusual items
910.00M
770.00M
1.52B
1.16B
Income tax expense
90.00M
60.00M
250.00M
90.00M
Effective tax rate
9.89%
8.96%
13.23%
7.76%
Other operating expenses
2.03B
2.17B
1.76B
2.18B
Net income
780.00M
590.00M
1.66B
1.06B
Net profit margin
9.97%
6.64%
15.75%
11.04%
Earnings per share
-
-
-
-
Interest and investment income
-
-
70.00M
-
Interest expense
-550.00M
-600.00M
-450.00M
-520.00M
Net interest expenses
-550.00M
-600.00M
-380.00M
-520.00M
Depreciation and amortization charges
530.00M
650.00M
530.00M
550.00M
EBITDA
1.62B
1.47B
2.74B
2.06B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps